Clinical outcome data for off-label medications: The more the better

Authors

  • Karen J. Psooy University of Manitoba Winnipeg Children's Hospital

DOI:

https://doi.org/10.5489/cuaj.2058

Keywords:

n/a

Downloads

Download data is not yet available.

Author Biography

Karen J. Psooy, University of Manitoba Winnipeg Children's Hospital

Associate Professor, University of Manitoba

Section Head, Urology

References

Nadeau G, Schröder A, Moore K, Genois L, Lamontagne P, Hamel M, Pellerin È, Bolduc S. Long-term use of solifenacin in pediatric patients with overactive bladder: extension of a prospective open-label study. Can Urol Assoc J 2014;XX:XX.

Bolduc S, Moore K, Nadeau G, Lebel S, Lamontagne P, Hamel M. Prospective open label study of solifenacin for overactive bladder in children. J Urol 2010;184(4 Suppl):1668-1673.

Downloads

Published

2014-04-14

How to Cite

Psooy, K. J. (2014). Clinical outcome data for off-label medications: The more the better. Canadian Urological Association Journal, 8(3-4), 124. https://doi.org/10.5489/cuaj.2058

Issue

Section

Commentary